U.S. market Closed. Opens in 1 hour

PMVP | PMV Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue1.26M650.00K1.28M318.00K388.00KN/A
Gross Profit-1.26M-650.00K-1.28M-318.00K-388.00KN/A
Operating Expenses80.13M77.04M58.29M34.94M26.64M18.89M
Selling, General & Admin24.25M25.05M21.80M11.01M5.88M5.04M
Research & Development55.88M51.99M36.49M23.93M20.76M13.85M
Other Operating ExpensesN/A87.00K21.00K-143.00K-8.00K16.00K
Operating Income-80.13M-77.04M-58.29M-34.94M-26.64M-18.89M
Other Expenses / Income11.17M3.71M470.00K508.00K1.29M16.00K
Before Tax Income-68.96M-73.33M-57.82M-34.43M-25.34M-17.54M
Income Tax Expenses2.00K-9.00K23.00K6.00K8.00K3.00K
Net Income-68.96M-73.32M-57.85M-34.44M-25.35M-17.54M
Interest ExpensesN/A-4.03MN/AN/AN/AN/A
Basic Shares Outstanding48.01M45.59M45.14M44.78M43.00M31.23M
Diluted Shares Outstanding48.01M45.59M45.14M44.78M43.00M31.23M
EBITDA-78.88M-77.04M-58.29M-34.94M-26.25M-18.55M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-68.96M-77.36M-57.82M-34.43M-25.34M-17.54M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙